Highlights and Quick Summary
- Financing cash flow for the quarter ending September 30, 2022 was $-2.27 Million (a -110.23% decrease compared to previous quarter)
- Year-over-year quarterly Financing cash flow decreased by -48.09%
- Annual Financing cash flow for 2021 was $1.26 Million (a -98.44% decrease from previous year)
- Annual Financing cash flow for 2020 was $81.1 Million (a 253.17% increase from previous year)
- Annual Financing cash flow for 2019 was $23 Million (a 20.7% increase from previous year)
- Twelve month Financing cash flow ending September 30, 2022 was $12.7 Million (a -17.36% decrease compared to previous quarter)
- Twelve month trailing Financing cash flow increased by 904.04% year-over-year
Trailing Financing cash flow for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $12.7 Million | $15.3 Million | $-6.52 Million | $1.26 Million |
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Financing cash flow of Biodesix, Inc.
Most recent Financing cash flowof BDSX including historical data for past 10 years.Interactive Chart of Financing cash flow of Biodesix, Inc.
Biodesix, Inc. Financing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-2.27 | $22.13 | $-2.83 | – |
| 2021 | $-4.36 | $0.4 | $0.28 | $4.95 | $1.26 |
| 2020 | $65.08 | $0.01 | $9.63 | $6.42 | $81.13 |
| 2019 | – | – | $2.94 | $20.03 | $22.97 |
| 2018 | – | – | – | – | $19.03 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research